ResearcherNorth Sichuan Medical UniversityNo recent work listed

Xiaobin Huang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9480-1244; OpenAlex author ID A5044883681. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 6

Papers, trials and grants by year

2022: 1 paper

Papers 1

Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer via the Wnt/β-catenin pathway Co-author DOI 10.21203/rs.3.rs-1976828/v1 ↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Guangnian Zhang · 1 shared paper, 2022 · strength 0.13
- Paper Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer… DOI 10.21203/rs.3.rs-1976828/v1 ↗
Jianshui Li · 1 shared paper, 2022 · strength 0.13
- Paper Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer… DOI 10.21203/rs.3.rs-1976828/v1 ↗
Dawei Deng · 1 shared paper, 2022 · strength 0.13
- Paper Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer… DOI 10.21203/rs.3.rs-1976828/v1 ↗
Chuan Lan · 1 shared paper, 2022 · strength 0.13
- Paper Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer… DOI 10.21203/rs.3.rs-1976828/v1 ↗
Jun Yu · 1 shared paper, 2022 · strength 0.13
- Paper Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer… DOI 10.21203/rs.3.rs-1976828/v1 ↗
Xingyu Liu · 1 shared paper, 2022 · strength 0.13
- Paper Catenin delta 1 mediates epithelial–mesenchymal transition, proliferation, migration, and invasion of pancreatic cancer… DOI 10.21203/rs.3.rs-1976828/v1 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.